HI homepage

Trending
Fewer than 30% of FDA-cleared AI devices share key safety, adverse event info prior to approval
Does BMI affect AI's accuracy when assessing CT scans?
New GE HealthCare partnership expands access to prostate cancer imaging agent
Repetitive head impact in soccer players increases risk of brain damage, MRI shows
Expert panel develops new breast biopsy guidelines
Howard Berger, MD, RadNet chairman and CEO, discusses why the company has invested millions into DeepHealth to rapidly build up a new business model for artificial intelligence capabilities in radiology. #RSNA #HealthAI #ClinicalAI #Radiology
Why RadNet is betting heavily on AI to reshape radiology workflows

RadNet Chaiman and CEO Howard Berger, MD, explains why the company has invested tens of millions into DeepHealth to rapidly build up a new business model. 

 

Congress Senate Washington D.C. DC
Republicans win shutdown showdown—Senate agrees to funding deal without ACA subsidy extension

With eight Democrats agreeing to the Republican-backed deal that reverses the firings of federal workers, the Senate now has the 60 votes needed for the bill to advance. The rehirings will include the 1,200 workers fired at the Department of Health and Human Services. 

lung cancer screening
Study highlights CT findings that could mask lung cancer, leading to delayed diagnosis

For many patients with interstitial lung disease, cancer could go undetected for years, putting them at risk of disease progression that would require more extensive treatment.
AI ups detection of small prostate lesions by nearly 20%

Many experts believe that artifcial intelligence could help address issues with reader variability on prostate MRIs. 

Ultromics EchoGo Amyloidosis artificial intelligence. A first of its kind AI model developed by Mayo Clinic and Ultromics Ltd., was found to be highly accurate in screening for cardiac amyloidosis in a large 2,612 patient clinical trial. The findings were published in the European Heart Journal.[1] Mayo Clinic, investigators at the University of Chicago Medicine and collaborators around the world at other sites, validated and tested the model on a large and multi-ethnic population.
AI-enhanced echocardiography improves early detection of cardiac amyloidosis

The first FDA-cleared AI model of its kind was found to be an accurate screening tool for cardiac amyloidosis.
AI algorithm that diagnoses depression from MRI scans gains key regulatory approval

Experts are hopeful the software can bring more objectivity to the diagnostic process by giving providers visual evidence of alterations in brain activity.

Recall | Product recall
Software glitch triggers FDA recall of nearly 2,000 GE SPECT and CT systems

According to the notification, the issue can cause the scanners to inadvertently move during imaging. 

American Medical Association (AMA) Board of Trustees Member Scott Ferguson, MD, FACR, a diagnostic radiologist, explains the concern AMA has over the large number of rural hospitals closing and the shrinking access to medical care across large swaths of the U.S. He said the Big Beautiful Bill passed by Congress in July 2025 will likely accelerate closures.
AMA very concerned 'Big, Beautiful Bill' will accelerate closure of more rural hospitals

American Medical Association (AMA) Board of Trustees Member Scott Ferguson, MD, explains the concern that a large number of rural hospitals will close under the massive Medicaid cuts in the "Big, Beautiful Bill" passed by Congress in July 2025.  

HeartFlow Plaque Analysis Example
AI-enabled coronary plaque evaluations included in new RBM guidelines

The use of advanced AI software to assess CCTA images continues to gain more momentum.

Around the web

Radiology Business
Why RadNet is betting heavily on AI to reshape radiology workflows

RadNet Chaiman and CEO Howard Berger, MD, explains why the company has invested tens of millions into DeepHealth to rapidly build up a new business model. 

 

Cardiovascular Business
AI turns mammograms into CVD risk assessments—no outside data required

Thanks to AI, clinicians can use mammograms to do a lot more than identify signs of breast cancer. Researchers explored data from nearly 50,000 patients, presenting their findings in Heart.

Radiology Business
Fewer than 30% of FDA-cleared AI devices share key safety, adverse event info prior to approval

A new analysis is prompting questions regarding how rigorously many of the AI-enabled tools approved by the U.S. Food and Drug Administration are evaluated prior to their clearance.